Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa (VL-DX-EAFR)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
A observational or N/A phase clinical study on Leishmaniasis, Visceral, this trial is completed. The trial is conducted by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2022 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Jan 2021 — Jul 2022 [monthly]
Unknown Status
▶ Show 2 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Sep 2018 — Sep 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Drugs for Neglected Diseases
- Foundation for Innovative New Diagnostics, Switzerland
- Kenya Medical Research Institute
- London School of Hygiene and Tropical Medicine
- University of Gondar
For direct contact, visit the study record on ClinicalTrials.gov .